Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.
NCT06030895
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Sorafenib Tablets
Sponsor
Damanhour University